Home > Insider Trading > Filing (0001179022-19-000023)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133416	Galectin Therapeutics Inc	GALT	Pharmaceutical Preparations (2834)	043562325

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1694903	E Richard Uihlein	12575 Uline Drive Pleasant Prairie WI 53158		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-01-28	3,000	$4.77	2,538,289	No	4	P	Direct
Common Stock	Acquisiton	2019-01-29	48,500	$4.87	2,586,789	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The shares were purchased in multiple transactions at prices ranging from $4.77 to $4.78. This amount represents the weighted average purchase price of such transactions. The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
The shares were purchased in multiple transactions at prices ranging from $4.75 to $5.00. This amount represents the weighted average purchase price of such transactions. The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
This Form 4 is being amended to correct footnotes (1) and (2) for the purchase transactions on January 28, 2019 and January 29, 2019, which footnotes incorrectly stated that the shares were sold in multiple transactions, but should have stated that the shares were purchased in multiple transactions.